切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2015, Vol. 12 ›› Issue (11) : 840 -844. doi: 10.3877/cma.j.issn.1672-6448.2015.11.005

所属专题: 妇产科超声影像学 产前超声 文献 妇产科超声

综述

胎儿染色体微小异常的再认识
张葵1, 李胜利1,()   
  1. 1. 518028 南方医科大学附属深圳市妇幼保健院超声科
  • 收稿日期:2015-09-08 出版日期:2015-11-01
  • 通信作者: 李胜利
  • 基金资助:
    国家自然资金科学基金(60671043); 国家科技支撑计划(2014BAI06B05)

Examination of subtle fetal chromosomal findings

Kui Zhang1, Shengli Li1()   

  • Received:2015-09-08 Published:2015-11-01
  • Corresponding author: Shengli Li
引用本文:

张葵, 李胜利. 胎儿染色体微小异常的再认识[J]. 中华医学超声杂志(电子版), 2015, 12(11): 840-844.

Kui Zhang, Shengli Li. Examination of subtle fetal chromosomal findings[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2015, 12(11): 840-844.

表1 综合多篇文献报道的早孕期胎儿NT测量研究结果
表2 综合多篇文献报道的早孕期胎儿鼻骨检测研究结果
[1]
Loughna P. Soft markers: where are we now?[J]. Obstetrics, Gynaecology & Reproductive Medicine, 2009, 19(5): 127-129.
[2]
Loughna P. Soft markers for congenital anomaly [J]. Current Obstetrics & Gynaecology, 2003, 13: 110-113.
[3]
Smith-Bindman R, Hosmer W, Feldstein VA, et al. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis [J]. JAMA, 2001, 285(8): 1044-1055.
[4]
Ahman A, Axelsson O, Maras G, et al. Ultrasonographic fetal soft markers in a low-risk population: prevalence, association with trisomies and invasive tests [J]. Acta Obstet Gynecol Scand, 2014, 93(4): 367-373.
[5]
Rumack CM, Wilson SR, William CJ, et al. Diagnostic ultrasound [M]. 3th ed. Beijing: People′s Military Medical Press, 2005: 1163.
[6]
Pandya PP, Kondylios A, Hilbert L, et al. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency [J]. Ultrasound Obstet Gynecol, 1995, 5(1): 15-19
[7]
Cicero S, Curcio P, Papageorghiou A, et al. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study [J]. Lancet, 2001, 358(9294): 1665-1667.
[8]
Ting YH, Lao TT, Lau TK, et al. Isolated absent or hypoplastic nasal bone in the second trimester fetus: is amniocentesis necessary? [J]. J Matern Fetal Neonatal Med, 2011, 24(4): 555-558.
[9]
Pandya PP, Goldberg H, Walton B, et al. The implementation of first-trimester scanning at 10-13 weeks′ gestation and the measurement of fetal nuchal translucency thickness in two maternity units [J]. Ultrasound Obstet Gynecol, 1995, 5(1): 20-25.
[10]
Szabó J, Gellén J, Szemere G. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age [J]. Ultrasound Obstet Gynecol, 1995, 5(3): 161-163.
[11]
Pajkrt E, van Lith JM, Mol BW, et al. Screening for Down′s syndrome by fetal nuchal translucency measurement in a general obstetric population [J]. Ultrasound Obstet Gynecol, 1998, 12(3):163-169.
[12]
Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group [J]. Lancet, 1998, 352(9125): 343-346.
[13]
Economides DL, Whitlow BJ, Kadir R, et al. First trimester sonographic detection of chromosomal abnormalities in an unselected population [J]. Br J Obstet Gynaecol, 1998, 105(1): 58-62.
[14]
Schwärzler P, Carvalho JS, Senat MV, et al. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population [J]. Br J Obstet Gynaecol, 1999,106(10): 1029-1034.
[15]
Theodoropoulos P, Lolis D, Papageorgiou C, et al. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age [J]. Prenat Diagn, 1998, 18(2): 133-137.
[16]
Gasiorek-Wiens A, Tercanli S, Kozlowski P, et al. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland [J]. Ultrasound Obstet Gynecol, 2001, 18(6): 645-648.
[17]
Brizot ML, Carvalho MH, Liao AW, et al. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population [J]. Ultrasound Obstet Gynecol, 2001,18(6): 652-655.
[18]
Audibert F, Dommergues M, Benattar C, et al. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study [J]. Ultrasound Obstet Gynecol, 2001, 18(1): 26-31.
[19]
Otaño L, Aiello H, Igarzábal L, et al. Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome [J]. Prenat Diagn, 2002, 22(10): 930-932.
[20]
Zoppi MA, Ibba RM, Axiana C, et al. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies [J]. Prenat Diagn, 2003, 23(6): 496-500.
[21]
Orlandi F, Bilardo CM, Campogrande M, et al. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment [J]. Ultrasound Obstet Gynecol, 2003, 22(1): 36-39.
[22]
Viora E, Masturzo B, Errante G, et al. Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses [J]. Prenat Diagn, 2003, 23(10): 784-787.
[23]
Senat MV, Bernard JP, Boulvain M, et al. Intra- and interoperator variability in fetal nasal bone assessment at 11-14 weeks of gestation [J]. Ultrasound Obstet Gynecol, 2003, 22(2): 138-141.
[24]
Wong SF, Choi H, Ho LC. Nasal bone hypoplasia: is it a common finding amongst chromosomally normal fetuses of southern Chinese women? [J]. Gynecol Obstet Invest, 2003, 56(2): 99-101.
[25]
Cicero S, Longo D, Rembouskos G, et al. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects [J]. Ultrasound Obstet Gynecol, 2003, 22(1): 31-35.
[26]
Cicero S, Rembouskos G, Vandecruys H, et al. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan [J]. Ultrasound Obstet Gynecol, 2004, 23(3): 218-223.
[27]
Nicolaides KH. Turning the pyramid of prenatal care [J]. Fetal Diagn Ther, 2011, 29(3): 183-196.
[28]
Benacerraf BR. The role of the second trimester genetic sonogram in screening for fetal Down syndrome [J]. Semin Perinatol, 2005, 29(6): 386-394.
[29]
Forzano F, Mansour S, Ierullo A, et al. Posterior fossa malformation in fetuses: a report of 56 further cases and a review of the literature [J]. Prenat Diagn, 2007, 27(6): 495-501.
[30]
Lau TK, Cheung SW, Lo PS, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center [J]. Ultrasound Obstet Gynecol, 2014, 43(3): 254-264.
[31]
彭园园, 张艳华, 赵丽娟, 等. 孕妇血浆游离胎儿DNA检测在产前筛查中的临床应用[J/CD]. 中国产前诊断杂志:电子版, 2014, 6(3): 46-48.
[32]
Brady PD, Devriendt K, Deprest J, et al. Array-based approaches in prenatal diagnosis [J]. Methods Mol Biol, 2012, 838: 151-171.
No related articles found!
阅读次数
全文


摘要